KDM2A and central nervous system cancer: In our study, we found that KDM2A expression was elevated in glioma biopsy specimens and glioma cell lines and that lncRNA HOXA-AS2 positively regulated the expression of KDM2A to promote glioma cell proliferation and immune tolerance.